DaVita (DVA)
(Delayed Data from NYSE)
$141.16 USD
-1.00 (-0.70%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $141.08 -0.08 (-0.06%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
Brokerage Reports
0 items in cart
DaVita Inc. [DVA]
Reports for Purchase
Showing records 201 - 220 ( 287 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
4Q Results and Call Highlight Longer-Term Growth Uncertainties
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Downgrading on Valuation/Slightly Lower Growth Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Discontinuation of Research Coverage
Provider: FELTL & COMPANY
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid Kidney Care results overshadowed by weak HCP performance
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Reducing Estimates Slightly as HCP Continues to Stumble
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid 4Q13 results with management increasing 2014 guidance
Provider: FELTL & COMPANY
Analyst: WEIGHT M